were evaluated by microarray, quantitative RT-PCR (qRT-PCR), Cell Counting Kit-8(CCK-8) assay, glucose assay, lactate assay, transmission electron microscopy, as well as Western blot analysis. Dualluciferase reporter assay was used to identify the relationship between miR-361-5p, SP1, and PKM2.
INTRODUCTION AND OBJECTIVES: Solute carrier organic anion (SLCO) genes encode organic anion transport proteins, which is a family of transport proteins that influx number of substrates into the cells including androgens. Among them, high expression of SLCO genes, including SLCO1B3 and SLCO2B1, has been shown to be associated with the resistance to androgen deprivation therapy in prostate cancer. However, the significance of the expression of SLCO genes in the recurrence after radical prostatectomy has not been elucidated. Here, we hypothesized that the high expression of these SLCO genes in human prostate cancer is associated with the recurrence after radical prostatectomy.
METHODS: Clinical and RNA-seq data were all obtained from the Cancer Genome Atlas (TCGA). Patients were classified as either high or low expression of SLCO1B3 or SLCO2B1 by the mean value. Survival analysis and gene set enrichment analysis (GSEA) was conducted between high and low expression group in whole cohort, as well as by Gleason score (GS¼6, ¼7 or ¼8).
RESULTS: Patients were classified with the expression level of SLOC1B3 or SLCO2B1 by mean value of each gene. In overall survival, either of these genes was not related to survival. However, high expression group of SLCO2B1 showed significantly worse disease-free survival after radical prostatectomy (p¼0.026), whereas the expression level of SLCO1B3 was not related to disease-free survival. The patients with higher Gleason score had significantly higher levels of SLCO2B1 expression (GS<6 vs GS¼7; p¼0.045, GS¼7 vs GS>8; p¼0.002). Significant difference in disease-free survival between high and low expression groups were only observed in the patients with GS¼8 (p¼0.005), and not in the patients with GS¼7 (GS<6; p¼0.640, GS¼7; p¼0.923). GSEA demonstrated that in the high expression group of SLCO2B1 enriched epithelial mesenchymal transition signaling related genes.
CONCLUSIONS: High expression of SLCO2B1 in the prostate cancer patients associated with the aggressive cancer characteristics and recurrence after radical prostatectomy, however no relation was found with the expression level of SLCO1B3. Furthermore, the high recurrence rate of the patients with high expression of SLCO2B1 may be able to be explained by its metastatic potential with up-regulated EMT pathways.
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MP64-05 THE APPLICATION OF MINIMAL SCORE OF APPARENT DIFFUSION COEFFICIENT (ADC) IN PROSTATE MRI TO PREDICT THE PROSTATE CANCER MICROENVIRONMENT
Manabu Kato*, Tsu, Japan; Placencio Veronica, Los Angeles, CA; Kenichiro Ishii, Kohei Nishikawa, Kiminobu Arima, Yoshihumi Hirokawa, Masatoshi Watanabe, Yoshiki Sugimura, Tsu, Japan INTRODUCTION AND OBJECTIVES: Multi-parametric MRI and the mapping with Apparent Diffusion Coefficient (ADC) reinforce the accuracy for local detection of prostate cancer. It has been hard to predict the conditions of tumor microenvironment before the treatment. In this prostate tumor microenvironment, cancer-associated fibroblasts plays important role for cancer progression and invasion, and these components shows tendency of high expression for specific protein markers including Vimentin, CD105 and TNC-C. On the other hand, aSMA is commonly used as a marker of smooth muscle cells and expressed in the stroma area surrounding normal prostate grounds. In this study, we examined the MRI predictive availability for evaluation of prostate cancer microenvironment by comparing the pre-operation MRI images with the findings of immunohistochemistry (IHC) of prostate cancer surgical specimens. Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 THE JOURNAL OF UROLOGY â e851
